Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
about
Lipid metabolic reprogramming in cancer cellsThe HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice.Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.Ligand Binding Site Structure Influences the Evolution of Protein Complex Function and Topology.Drug Repositioning for Effective Prostate Cancer Treatment.
P2860
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Nelfinavir and other protease ...... nvolved in anticancer activity
@ast
Nelfinavir and other protease ...... nvolved in anticancer activity
@en
Nelfinavir and other protease ...... nvolved in anticancer activity
@nl
type
label
Nelfinavir and other protease ...... nvolved in anticancer activity
@ast
Nelfinavir and other protease ...... nvolved in anticancer activity
@en
Nelfinavir and other protease ...... nvolved in anticancer activity
@nl
prefLabel
Nelfinavir and other protease ...... nvolved in anticancer activity
@ast
Nelfinavir and other protease ...... nvolved in anticancer activity
@en
Nelfinavir and other protease ...... nvolved in anticancer activity
@nl
P2860
P1433
P1476
Nelfinavir and other protease ...... nvolved in anticancer activity
@en
P2093
Tomas Koltai
P2860
P356
10.12688/F1000RESEARCH.5827.2
P407
P577
2015-01-12T00:00:00Z